tiprankstipranks
Rising High: Exclusive talk with biopharma company HMNC Brain Health
PremiumThe FlyRising High: Exclusive talk with biopharma company HMNC Brain Health
22d ago
Prothena partner Roche PADOVA study misses primary endpoint
Premium
The Fly
Prothena partner Roche PADOVA study misses primary endpoint
23d ago
Roche announces PADOVA study misses statistical significance
Premium
The Fly
Roche announces PADOVA study misses statistical significance
23d ago
Roche says five-year results confirm Polivy combo as ‘new standard of care’
PremiumThe FlyRoche says five-year results confirm Polivy combo as ‘new standard of care’
1M ago
Genentech announces FDA acceptance of Columvi combination sBLA
Premium
The Fly
Genentech announces FDA acceptance of Columvi combination sBLA
1M ago
Roche price target raised to CHF 230 from CHF 220 at JPMorgan
Premium
The Fly
Roche price target raised to CHF 230 from CHF 220 at JPMorgan
1M ago
Poseida Therapeutics to be acquired by Roche for $9.00 per share plus CVR
PremiumThe FlyPoseida Therapeutics to be acquired by Roche for $9.00 per share plus CVR
2M ago
Roche announces FDA approval of label expansion into biliary tract cancer
Premium
The Fly
Roche announces FDA approval of label expansion into biliary tract cancer
2M ago
FDA grants accelerated approval to Jazz Pharmaceuticals’ Ziihera
Premium
The Fly
FDA grants accelerated approval to Jazz Pharmaceuticals’ Ziihera
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100